Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Patient-Level Model Predicts In-Hospital Cardiac Mortality

By HospiMedica International staff writers
Posted on 18 Aug 2016
Researchers at Yale University School of Medicine (Yale; New Haven, CT, USA), Duke University (Durham, NC, USA), and other institutions reviewed patient admittance characteristics in the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) registry database from January 2012 through December 2013, in order to develop a multivariate hierarchical logistic regression model to predict in-hospital mortality. More...
The study population, which included 243,440 patients from 655 hospitals, was divided into a 60% sample for model derivation, with the remaining 40% used for model validation.

The researchers found that in-hospital mortality was 4.6%, with independent associations for age, heart rate, systolic blood pressure, presentation after cardiac arrest, cardiogenic shock, and heart failure, presentation with ST-segment elevation myocardial infarction (STEMI), creatinine clearance, and troponin ratio. Upon model validation, the researchers found that it performed well in subgroups based on age, sex, race, transfer status, and presence of diabetes mellitus, renal dysfunction, cardiac arrest, cardiogenic shock, and STEMI. The study was published in the August 9, 2016, issue of the Journal of the American College of Cardiology (JACC).

“As a foundation for quality improvement, assessing clinical outcomes across hospitals requires appropriate risk adjustment to account for differences in patient case mix, including presentation after cardiac arrest,” concluded lead author Robert McNamara, MD, of Yale, and colleagues. “This parsimonious risk model for in-hospital mortality is a valid instrument for risk adjustment and risk stratification in contemporary patients with acute myocardial infarction.”

MI occurs following an ischemia that causes damage to heart muscle. The most common symptom is chest pain or discomfort, which may travel into the shoulder, arm, back, neck, or jaw. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or fatigue. Most MIs occur as a result of coronary artery disease (CAD), with risk factors including high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol intake.

Related Links:
Yale University School of Medicine
Duke University

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.